186 related articles for article (PubMed ID: 23161709)
1. Molecular pathology of breast cancer: what a pathologist needs to know.
Allison KH
Am J Clin Pathol; 2012 Dec; 138(6):770-80. PubMed ID: 23161709
[TBL] [Abstract][Full Text] [Related]
2. Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer.
Han HS; Magliocco AM
Clin Breast Cancer; 2016 Jun; 16(3):166-79. PubMed ID: 27103546
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.
Eroles P; Bosch A; Pérez-Fidalgo JA; Lluch A
Cancer Treat Rev; 2012 Oct; 38(6):698-707. PubMed ID: 22178455
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
5. A pathologist's perspective on emerging genomic tests for breast cancer.
Symmans WF
Semin Oncol; 2007 Apr; 34(2 Suppl 3):S4-9. PubMed ID: 17512433
[TBL] [Abstract][Full Text] [Related]
6. Pathological parameters useful in predicting prognosis for patients with breast cancer.
Hutter RV
Monogr Pathol; 1984; (25):175-85. PubMed ID: 6377048
[TBL] [Abstract][Full Text] [Related]
7. Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.
Diaz LK; Cryns VL; Symmans WF; Sneige N
Adv Anat Pathol; 2007 Nov; 14(6):419-30. PubMed ID: 18049131
[TBL] [Abstract][Full Text] [Related]
8. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.
Masood S
Surg Oncol Clin N Am; 1995 Oct; 4(4):601-32. PubMed ID: 8535901
[TBL] [Abstract][Full Text] [Related]
9. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
Kocjan G
Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of breast pathology data: implications for practising pathologists.
Deb R; Tan PH
J Clin Pathol; 2022 Aug; 75(8):514-518. PubMed ID: 35853656
[TBL] [Abstract][Full Text] [Related]
11. Benign breast lesions that mimic malignant tumors: analysis of five distinct lesions.
Weidner N
Semin Diagn Pathol; 1990 May; 7(2):90-101. PubMed ID: 2194262
[TBL] [Abstract][Full Text] [Related]
12. Mammographically directed breast biopsies: a College of American Pathologists Q-Probes study of clinical physician expectations and of specimen handling and reporting characteristics in 434 institutions.
Nakhleh RE; Jones B; Zarbo RJ
Arch Pathol Lab Med; 1997 Jan; 121(1):11-8. PubMed ID: 9111087
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing and treating breast cancer in elderly women: a call for improved understanding.
Downey L; Livingston R; Stopeck A
J Am Geriatr Soc; 2007 Oct; 55(10):1636-44. PubMed ID: 17727649
[TBL] [Abstract][Full Text] [Related]
14. EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy.
Milanezi F; Carvalho S; Schmitt FC
Expert Rev Mol Diagn; 2008 Jul; 8(4):417-34. PubMed ID: 18598224
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer in limited-resource countries: diagnosis and pathology.
Shyyan R; Masood S; Badwe RA; Errico KM; Liberman L; Ozmen V; Stalsberg H; Vargas H; Vass L;
Breast J; 2006; 12 Suppl 1():S27-37. PubMed ID: 16430396
[TBL] [Abstract][Full Text] [Related]
16. [Anatomo-pathologic examination of breast cancer: a prerequisite for optimal therapeutic choice].
Fridman V; Boniver J
Rev Med Liege; 1999 Oct; 54(10):796-800. PubMed ID: 10605313
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
Anderson BO; Shyyan R; Eniu A; Smith RA; Yip CH; Bese NS; Chow LW; Masood S; Ramsey SD; Carlson RW
Breast J; 2006; 12 Suppl 1():S3-15. PubMed ID: 16430397
[TBL] [Abstract][Full Text] [Related]
18. The expanding role of pathologists in the diagnosis and management of breast cancer: Worldwide Excellence in Breast Pathology Program.
Masood S;
Breast J; 2003; 9 Suppl 2():S94-7. PubMed ID: 12713504
[TBL] [Abstract][Full Text] [Related]
19. Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.
Andre F; Pusztai L
Nat Clin Pract Oncol; 2006 Nov; 3(11):621-32. PubMed ID: 17080180
[TBL] [Abstract][Full Text] [Related]
20. Genomics of adjuvant therapy for breast cancer.
Kim SR; Paik S
Cancer J; 2011; 17(6):500-4. PubMed ID: 22157294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
